Recent Advancement towards Treatment of Diabetes Panchal Ishan*, Panigrahi B, Patel CN Department of Pharmaceutical Chemistry, Shri Sarvajanik Pharmacy College, Mehsana, India *Corresponding Author: Ishan Panchal, Department of Pharmaceutical Chemistry, Shri Sarvajanik Pharmacy College, Mehsana, India. E-Mail: ishanpharma@gmail.com
Online published on 20 March, 2013. Abstract Diabetes is a chronic disease that occurs when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Diabetes can damage the heart, blood vessels, eyes, kidneys, and nerves. In 2030, the figure of diabetic patients is expected to rise to 366 million. Diabetes is the fourth leading cause of global death by disease. Each year diabetes accounts for 3.8 million deaths. This article deals with recent advancement to wards treatment of diabetes. First it reviews emerging targets for diabetes like PTP-1B inhibitors, GSK-3 inhibitors and DPP-4 inhibitors. Second it describes recent nanotechnology research in the detection of insulin and blood sugar by implantable sensor and microphysiometer. In addition latest stem cell research occurs in diabetes treatment. At last this article give idea about working of insulin pump, glossary of pump and how pump can reduce the risk of complication of diabetes. Top Keywords diabetes, PTP-1B inhibitors, GSK-3 inhibitors, DPP-4 inhibitors, nanotechnology, insulin pump, stem cell. Top |